Interview with our CEO Dr. Reto Naef in Credit Suisse’s publication “BULLETIN”

CS Bulletin 3/2018:

In the middle of the city of Zurich’s “Westside” the scientific development of future ground-breaking drug medicine for the world is taking place. Part of the Bio-Technopark in Schlieren is also TOPADUR PHARMA AG. Follow us for a visit in Schlieren’s sophisticated Bio-Technopark.

An embedded interview with our CEO Dr. Reto Naef about the cooperation and teamwork at the Bio-Technopark Schlieren can be found here.